Ahmed青光眼引流阀植入术治疗玻璃体切除术后难治性青光眼
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

重庆市卫计委科研课题资助项目(No.2011-2-326)


Clinical research of Ahmed glaucoma valve implantation on glaucoma secondary to vitrectomy surgeries
Author:
Affiliation:

Fund Project:

Scientific Research Foundation of Chongqing Health and Family Planning Commission(No.2011-2-326)

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:评价Ahmed 青光眼阀植入术治疗玻璃体手术后继发性青光眼的临床疗效。

    方法:回顾分析在我院眼科应用Ahmed青光眼阀植入术治疗玻璃体手术后继发性青光眼患者23例23眼。

    结果:患者术后平均随访29±3.7mo,术前平均眼压48.79±7.12mmHg,手术后24mo时平均眼压23.28±10.53mmHg,与术前眼压相比明显降低,具有显著性统计学差异(P<0.05); 术后1mo时,手术成功率82.6%,随访12、24mo时手术成功率分别为65.2%、52.2%。

    结论:采用Ahmed青光眼阀植入术治疗玻璃体手术后的继发性青光眼是比较有效和相对安全的治疗方法。

    Abstract:

    AIM:To evaluate the outcome of Ahmed glaucoma valve implantation on treating glaucoma secondary to vitrectomy surgeries.

    METHODS:Twenty-three eyes in 23 patients from our hospital treated with Ahmed valve implantations for their glaucoma secondary to vitrectomy surgeries were enrolled and their data was retrospectively analyzed.

    RESULTS:The average following-up was 29±3.7mo. Before implantations, the mean intraocular pressure(IOP)was 48.79±7.12mmHg. After 24mo of operations the mean IOP was 23.28±10.53mmHg, and there was significant difference compared with that pre-operation(P<0.05). at 1,12 and 24mo after operations, success rate of the implantation was 82.6%, 65.2% and 52.2%, respectively.

    CONCLUSION:Ahmed valve implantation is an effective and relatively safe method for the treatment of glaucoma secondary to vitrectomy surgeries.

    参考文献
    相似文献
    引证文献
引用本文

聂昕,谯雁彬. Ahmed青光眼引流阀植入术治疗玻璃体切除术后难治性青光眼.国际眼科杂志, 2015,15(11):1993-1995.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2015-07-09
  • 最后修改日期:2015-10-21
  • 录用日期:
  • 在线发布日期: 2015-10-30
  • 出版日期:
文章二维码